Share Twitter Facebook LinkedIn Email Briumvi is now commercially available for patients with active, relapsing forms of MS in Europe, where it is marketed by Neuraxpharm. Read More
Delta Opens New Travel Gateway to Asia with Salt Lake City’s First Nonstop Flight to Seoul – Travel And Tour WorldOctober 5, 2024